# Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency

> **NCT04786769** · PHASE4 · UNKNOWN · sponsor: **Hospital de Santa Cruz, Portugal** · enrollment: 2500 (estimated)

## Conditions studied

- Aortic Stenosis
- Iron-deficiency

## Interventions

- **DRUG:** Ferric carboxymaltose

## Key facts

- **NCT ID:** NCT04786769
- **Lead sponsor:** Hospital de Santa Cruz, Portugal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-06
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04786769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04786769, "Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04786769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*